CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-11 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −25,980 | $1.13 | $29K | 160,817 |
| 2023-03-11 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −59,737 | 0 | ||
| 2023-03-11 | KIES PETER CFO | Option exercise | +59,737 | 268,409 | ||
| 2023-03-11 | KIES PETER CFO | Shares withheld for taxes | −31,410 | $1.13 | $35K | 236,999 |
| 2023-03-11 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −59,737 | 0 | ||
| 2023-02-27 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +836,800 | 836,800 | ||
| 2023-02-27 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +225,000 | 225,000 | ||
| 2023-02-27 | KIES PETER CFO | Grant or award · Common Stock Option | +225,000 | 225,000 | ||
| 2023-02-27 | Weiner David B. Director | Sale | −11,668 | $1.28 | $15K | 904,291 |
| 2023-02-27 | Weiner David B. Director | Grant or award · Common Stock Option | +60,000 | 60,000 | ||
| 2023-02-27 | Weiner David B. Director | Grant or award · Restricted Stock Unit | +35,000 | 35,000 | ||
| 2023-02-27 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +112,500 | 112,500 | ||
| 2023-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +22,544 | 99,099 | ||
| 2023-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −9,788 | $1.28 | $13K | 89,311 |
| 2023-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +70,234 | 159,545 | ||
| 2023-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −32,485 | $1.28 | $42K | 127,060 |
| 2023-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −22,544 | 22,544 | ||
| 2023-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −70,234 | 140,466 | ||
| 2023-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +22,544 | 157,228 | ||
| 2023-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −9,069 | $1.28 | $12K | 148,159 |
Page 15 of 17 · 322 trades